Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment
Clinical trial NCT07160686 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07160686
- Sponsor
- University of Birmingham
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2029-09-30
- Enrollment
- 1456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.